Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Hermansen

Kevin Hermansen, Oslo NO

Patent application numberDescriptionPublished
20120041737Dynamic reservoir characterization - Method for dynamic reservoir characterization by generating, and visually presenting a three-dimensional reservoir model defined by a data set of cells, each cell describing a geometric shape in space and time having an array of physical properties.02-16-2012

Kjeld Hermansen, Ega DK

Patent application numberDescriptionPublished
20080318866MEDICAMENT FOR TREATMENT OF NON-INSULIN DEPENDENT DIABETES MELLITUS, HYPERTENSION AND/OR METABOLIC SYNDROME - A substance including the chemical structures of bicyclo [3.2.1]octan or the chemical structures of kaurene for the use in a dietary supplementation or as a constituent in a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome. The unique chemical structures of bicyclo [3.2.1]octan alone or in a kaurene structure provides the substances, such as e.g. steviol, isosteviol and stevioside with the capability of enhancing or potentiating the secretion of insulin in a plasma glucose dependent manner. The substances including these unique chemical structures also have the capability of reducing the glucagon concentration in the blood and/or lowering the blood pressure thereby providing a self-regulatory treatment system for non-insulin dependent diabetes mellitus and/or hypertension. In a combination drug which also comprise a soy protein, and/or soy fiber and/or at least one isoflavone these substances act synergistically and such combination drugs are highly useful both prophylacticly or directly in the treatment of e.g. the metabolic syndrome and obesity and has due to the self-regulatory effect a widespread applicability as a dietary supplementation.12-25-2008
20100093861TREATMENT OF INSULIN RESISTANCE OR DISEASES ASSOCIATED WITH INSULIN RESISTANCE - The present invention relates to the use of a substance with the core structure of formula (I), or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the manufacture of a composition for the treatment of insulin resistance or diseases associated with insulin resistance, preferably in human subject in a daily dosage in a range of from about 5 mg to about 1500 mg. The invention furthermore relates to a method of treating insulin resistance or diseases associated with insulin resistance in a mammal, said method comprises administering to said mamma, preferably a human subject, a substance with the core structure of formula (I), preferably in a daily dosage in a range from about 5 mg to about 1500 mg. The substance is preferably isosteviol or steviol, or pharmaceutically acceptable salts, solvates or prodrugs thereof. Examples of diseases associated with insulin resistance are e.g. type 2 diabetes mellitus, insulin resistance syndrome, impaired glucose tolerance, the metabolic syndrome, hyperglycemia, hyperinsulinemia, arteriosclerosis, hypercholesterolemia, hypertriglyceridemia, hyperlipidemia, dyslipidemia, obesity, central obesity, polycystic ovarian syndrome, hypercoagulability, hypertension, microalbuminuria, or any combinations thereof.04-15-2010
20110038827ELEVATION OF THE PLASMA HDL-CHOLESTEROL LEVEL - The present invention relates to the use of isosteviol, steviol, and related compounds for elevating the plasma HDL-cholesterol level. The invention furthermore relates to the use of these compounds for reducing the body weight of a subject and/or lowering the plasma triglyceride level of a subject, including a concomitant elevation of the plasma HDL-cholesterol level. Preferably the compounds used are isosteviol and/or steviol, or pharmaceutically acceptable salts, solvates or prodrugs thereof. The compounds may furthermore be administered in combination with one or more further active compounds, such as e.g. LDL-cholesterol lowering agents. The invention furthermore relates to a method for elevating the plasma HDL-cholesterol level in a subject by administering to a subject in need of such treatment a plasma HDL-cholesterol level elevating amount of the compounds, described herein.02-17-2011

Patent applications by Kjeld Hermansen, Ega DK

Kjeld Hermansen, Gistrup DK

Patent application numberDescriptionPublished
20090285406METHOD OF FITTING A PORTABLE COMMUNICATION DEVICE TO A HEARING IMPAIRED USER - The present invention relates to a method of adapting signal processing characteristics of a portable communication device to a hearing impaired user, comprising the steps of determining a perceptual reference level (PRL) of a first stimuli signal (FSS) in a reference frequency band (RFB) by presenting said first stimuli signal (FSS) to said hearing impaired user, and obtaining perceptual judgements of a loudness of said first stimuli signal (FSS) from said hearing impaired user, and determining said perceptual reference level (PRL) of a second stimuli signal (SSS) in a further frequency band (FFB) by presenting said second stimuli signal (SSS) to said hearing impaired user, and requesting said hearing impaired user to compare a loudness of said second stimuli signal (SSS) with said loudness of said first stimuli signal (FSS).11-19-2009

Leif Hermansen, Vesteroy NO

Patent application numberDescriptionPublished
20090159626Carrier rack for a bicycle - Users of cycles are limited in the amount that they can carry with them as luggage, owing to the need of having both hands to ride the cycle. Cycle carriers, therefore, provide a convenient way of allowing items to be carried by a cyclist, with the cycle and not the rider bearing the weight of the items. Many carriers, however, are designed for permanent attachment to cycles, this is not always appropriate if the cycle is to be used for other types of riding, where the carrier could be cumbersome or provide a hazard. To overcome such problems, a carrier (06-25-2009

Morten Green Hermansen, Copenhagen DK

Patent application numberDescriptionPublished
20110014945Apparatus and Method for Providing a User with a Personal Exercise Program - A convenient device, such as a mobile phone, provides a user interface for a system that generated personalised exercise programs and guides users through the exercises in a generated program. The generation of the program may be performed by the device providing the user interface.01-20-2011
20110151420APPARATUS AND METHOD FOR PROVIDING A USER WITH A PERSONAL EXERCISE PROGRAM - A convenient device, such as a mobile phone, provides a user interface for a system that generated personalised exercise programs and guides users through the exercises in a generated program. The generation of the program may be performed by the device providing the user interface.06-23-2011